Screener
Sionna Therapeutics SION Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Other current liabilities | 17 | 6 |
| Total current liabilities | 9,776 | 11,712 |
| Operating lease liability, noncurrent | 7,055 | 7,408 |
| Total liabilities | 16,831 | 19,120 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 45 | 45 |
| Additional paid-in capital | 571,380 | 562,602 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's total liabilities?
- Sionna Therapeutics (SION) reported total liabilities of $16.83M in Q1 2026.
- How has Sionna Therapeutics's total liabilities changed year-over-year?
- Sionna Therapeutics's total liabilities decreased by 6.0% year-over-year, from $17.91M to $16.83M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Sionna Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude